Phibro Animal Health vs Trulieve Cannabis
Phibro Animal Health is the larger business, with $1.52bn of revenue in fiscal 2026 against $1.18bn for Trulieve Cannabis (1.3 times as much). Phibro Animal Health grew faster (17.1% against -0.4%). Phibro Animal Health kept more of each dollar of sales as profit: a net margin of 6.6% against -9.9%.
| Latest fiscal year | Phibro Animal HealthPAHC, 2026 | Trulieve CannabisTRLV, 2025 |
|---|---|---|
| Revenue | $1.52bn | $1.18bn |
| Revenue growth | 17.1% | -0.4% |
| Net income | $99.7m | −$116m |
| Operating margin | — | 12.1% |
| Net margin | 6.6% | -9.9% |
| Return on equity | 29.7% | -9.7% |
| Free cash flow | $9.9m | $229m |
| Cash | $61.4m | $256m |
| Total debt | $738m | $141m |
| Debt to equity | — | 12.3% |
| Dividend per share | $0.48 | — |
| Dividend yield | 1.2% | — |
| Share buybacks | — | — |
| Employees | 2,605 | 5,000 |
| Market value | $1.53bn | $2.20bn |
| Price vs our value range | Within our value range | Below our value range |
| Moat score | 49 (Moderate) | 28 (Weak) |
| Insider trades, 12 months | 1 buys, 109 sales | 0 buys, 7 sales |